Measles virus (MV) enters cells by membrane fusion at the cell surface at neutral pH. Two glycoproteins mediate this process: the hemagglutinin (H) and fusion (F) proteins. The H-protein binds to receptors, while the F-protein mediates fusion of the viral and cellular membranes. H naturally interacts with at least three different receptors. The wild-type virus primarily uses the signaling lymphocyte activation molecule (SLAM, CD150) expressed on certain lymphatic cells, while the vaccine strain has gained the ability to also use the ubiquitous membrane cofactor protein (MCP, CD46), a regulator of complement activation. Additionally, MV infects polarized epithelial cells through an unidentified receptor (EpR). The footprints of the three receptors on H have been characterized, and the focus of research is shifting to the characterization of receptor-specific conformational changes that occur in the H-protein dimer and how these are transmitted to the F-protein trimer. It was also shown that MV attachment and cell entry can be readily targeted to designated receptors by adding specificity determinants to the H-protein. These studies have contributed to our understanding of membrane fusion by the glycopro-tein complex of paramyxoviruses in general.
Chapter PDF
References
Alkhatib Briedis DJ (1986) The predicted primary structure of the measles virus hemagglutinin. Virology 150:479–490
Armstrong MA, Fraser KB, Dermott E, Shirodaria PV (1982) Immunoelectron microscopic studies on haemagglutinin and haemolysin of measles virus in infected HEp2 cells. J Gen Virol 59:187–192
Bartz R, Brinckmann U, Dunster LM, Rima B, ter Meulen V, Schneider-Schaulies J (1996) Mapping amino acids of the measles virus hemagglutinin responsible for receptor (CD46) downregulation. Virology 224:334–337
Bolt G, Pedersen IR (1998) The role of subtilisin-like proprotein convertases for cleavage of the measles virus fusion glycoprotein in different cell types. Virology 252:387–398
Bucheit AD, Kumar S, Grote DM, Lin Y, von Messling V, Cattaneo RB, Fielding AK (2003) An oncolytic measles virus engineered to enter cells through the CD20 antigen. Mol Ther 7:62–72
Buchholz CJ, Schneider U, Devaux P, Gerlier D, Cattaneo R (1996) Cell entry by measles virus: long hybrid receptors uncouple binding from membrane fusion. J Virol 70:3716–3723
Buchholz CJ, Koller D, Devaux P, Mumenthaler C, Schneider-Schaulies J, Braun W, et al (1997) Mapping of the primary binding site of measles virus to its receptor CD46. J Biol Chem 272:22072–22079
Buckland R, Malvoisin E, Beauverger P, Wild F (1992) A leucine zipper structure present in the measles virus fusion protein is not required for its tetramerization but is essential for fusion. J Gen Virol 73:1703–1707
Buechi M, Bachi T (1982) Microscopy of internal structures of Sendai virus associated with the cytoplasmic surface of host membranes. Virology 120:349–359
Casali P, Sissons JG, Fujinami RS, Oldstone MB (1981) Purification of measles virus glycoproteins and their integration into artificial lipid membranes. J Gen Virol 54:161–171
Casasnovas JM, Larvie M, Stehle T (1999) Crystal structure of two CD46 domains reveals an extended measles virus-binding surface. EMBO J 18:2911–2922
Cathomen T, Mrkic B, Spehner D, Drillien R, Naef R, Pavlovic J, et al (1998) A matrix-less measles virus is infectious and elicits extensive cell fusion: consequences for propagation in the brain. EMBO J 17:3899–3908
Cattaneo R, Rose JK (1993) Cell fusion by the envelope glycoproteins of persistent measles viruses which caused lethal human brain disease. J Virol 67:1493–1502
Cherry J (2003) Measles virus. In: Buck C, Demmler G, Kaplan S (eds) Textbook of pediatric infectious diseases. Elsevier, pp 2283–2304
Cocks BG, Chang CC, Carballido JM, Yssel H, de Vries JE, Aversa G (1995) A novel receptor involved in T-cell activation. Nature 376:260–263
Colf LA, Juo ZS, Garcia KC (2007) Structure of the measles virus hemagglutinin. Nat Struct Mol Biol 14:1227–1228
Condack C, Grivel JC, Devaux P, Margolis L, Cattaneo R (2007) Measles virus vaccine attenuation: suboptimal infection of lymphatic tissue and tropism alteration. J Infect Dis 196:541–549
Corey EA, Iorio RM (2007) Mutations in the stalk of the measles virus hemagglutinin protein decrease fusion but do not interfere with virus-specific interaction with the homologous fusion protein. J Virol 81:9900–9910
Crennell S, Takimoto T, Portner A, Taylor G (2000) Crystal structure of the multifunctional para-myxovirus hemagglutinin-neuraminidase. Nat Struct Biol 7:1068–1074
de Swart RL, Ludlow M, de Witte L, Yanagi Y, van Amerongen G, McQuaid S, et al (2007) Predominant infection of CD150 + lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 3:1771–1781
Devaux P, Buchholz CJ, Schneider U, Escoffier C, Cattaneo R, Gerlier D (1997) CD46 short consensus repeats III and IV enhance measles virus binding but impair soluble hemagglutinin binding. J Virol 71:4157–4160
Dorig RE, Marcil A, Chopra A, Richardson CD (1993) The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295–305
Erlenhoefer C, Wurzer WJ, Loffler S, Schneider-Schaulies S, ter Meulen V, Schneider-Schaulies J (2001) CD150 (SLAM) is a receptor for measles virus but is not involved in viral contact-mediated proliferation inhibition. J Virol 75:4499–4505
Fournier P, Brons NH, Berbers GA, Wiesmuller KH, Fleckenstein BT, Schneider F, et al (1997) Antibodies to a new linear site at the topographical or functional interface between the hae-magglutinin and fusion proteins protect against measles encephalitis. J Gen Virol 78:1295–1302
Funke S, Maisner A, Mühlebach MD, Koehl U, Grez M, Cattaneo R, et al (2008) Targeted cell entry of lentiviral vectors. Mol Ther 16(8):1427–1436
Griffin DE (2007) Measles virus. In: Knipe DM, Howley PM (eds) Fields' virology. Lippincott Williams and Wilkins, Philadelphia, pp 1551–1585
Hallak LK, Merchan JR, Storgard CM, Loftus JC, Russell SJ (2005) Targeted measles virus vector displaying Echistatin infects endothelial cells via alpha(v)beta3 and leads to tumor regression. Cancer Res 65:5292–5300
Hammond AL, Plemper RK, Zhang J, Schneider U, Russell SJ, Cattaneo R (2001) Single-chain antibody displayed on a recombinant measles virus confers entry through the tumor-associated carcinoembryonic antigen. J Virol 75:2087–2096
Hashiguchi T, Kajikawa M, Maita N, Takeda M, Kuroki K, Sasaki K, et al (2007) Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci U S A 104:19535–19540
Hsu EC, Sarangi F, Iorio C, Sidhu MS, Udem SA, Dillehay DL, et al (1998) A single amino acid change in the hemagglutinin protein of measles virus determines its ability to bind CD46 and reveals another receptor on marmoset B cells. J Virol 72:2905–2916
Hsu EC, Sabatinos S, Hoedemaeker FJ, Rose DR, Richardson CD (1999) Use of site-specific mutagenesis and monoclonal antibodies to map regions of CD46 that interact with measles virus H protein. Virology 258:314–326
Hsu EC, Iorio C, Sarangi F, Khine AA, Richardson CD (2001) CDw150(SLAM) is a receptor for a lymphotropic strain of measles virus and may account for the immunosuppressive properties of this virus. Virology 279:9–21
Hu A, Cathomen T, Cattaneo R, Norrby E (1995) Influence of N-linked oligosaccharide chains on the processing, cell surface expression and function of the measles virus fusion protein. J Gen Virol 76:705–710
Kielian M, Rey FA (2006) Virus membrane-fusion proteins: more than one way to make a hairpin. Nat Rev Microbiol 4:67–76
Lamb RA (1993) Paramyxovirus fusion: a hypothesis for changes. Virology 197:1–11
Lamb RA, Parks GD (2007) Paramyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams and Wilkins, Philadelphia, pp 1449–1496
Lawrence MC, Borg NA, Streltsov VA, Pilling PA, Epa VC, Varghese JN, et al (2004) Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J Mol Biol 335:1343–1357
Lecouturier V, Fayolle J, Caballero M, Carabana J, Celma ML, Fernandez-Munoz R, et al (1996) Identification of two amino acids in the hemagglutinin glycoprotein of measles virus (MV) that govern hemadsorption HeLa cell fusion, and CD46 downregulation: phenotypic markers that differentiate vaccine and wild-type MV strains. J Virol 70:4200–4204
Leonard VHJ, Sinn PL, Hodge G, Miest T, Devaux P, Oezguen N, et al (2008) Epithelial cell receptor-blind measles virus remains virulent but cannot cross epithelia and is not shed. J Clin Invest 118(7):2448–2458
Liu TC, Galanis E, Kirn D (2007) Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress. Nat Clin Pract Oncol 4:101–117
Ludwig Schade B, Bottcher C, Korte T, Ohlwein N, Baljinnyam B, et al (2008) Electron cryo-microscopy reveals different F1+F2 protein states in intact parainfluenza virions. J Virol 82:3775–3781
Manchester M, Gairin JE, Patterson JB, Alvarez J, Liszewski MK, Eto DS, et al (1997) Measles virus recognizes its receptor CD46, via two distinct binding domains within SCR1–2. Virology 233:174–184
Masse N, Ainouze M, Neel B, Wild TF, Buckland R, Langedijk JP (2004) Measles virus (MV) hemagglutinin: evidence that attachment sites for MV receptors SLAM and CD46 overlap on the globular head. J Virol 78:9051–9063
McGinnes LW, Morrison TG (2006) Inhibition of receptor binding stabilizes Newcastle disease virus HN and F protein-containing complexes. J Virol 80:2894–2903
Mühlebach MD, Leonard VHJ, Cattaneo R (2008) The measles virus fusion protein transmem-brane region controls formation of an active glycoprotein complex and fusion efficiency. J Virol (in press)
Nakamura T, Peng KW, Vongpunsawad S, Harvey M, Mizuguchi H, Hayakawa T, et al (2004) Antibody-targeted cell fusion. Nat Biotechnol 22:331–336
Nakamura T, Peng KW, Harvey M, Greiner S, Lorimer IA, James CD, Russell SJ (2005) Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol 23: 209–214
Naniche Varior-Krishnan G, Cervoni F, Wild TF, Rossi B, Rabourdin-Combe C, Gerlier D (1993) Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 67:6025–6032
Navaratnarajah CK, Vongpunsawad S, Oezguen N, Stehle T, Braun W, Hashiguchi T, et al (2008) Dynamic Interaction of the measles virus hemagglutinin with its receptor signaling lym-phocytic activation molecule (SLAM, CD150). J Biol Chem 283:11763–11771
Ohno Seki F, Ono N, Yanagi Y (2003) Histidine at position 61 and its adjacent amino acid residues are critical for the ability of SLAM (CD150) to act as a cellular receptor for measles virus. J Gen Virol 84:2381–2388
Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, Yanagi Y (2001a) Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol 75:4399–4401
Ono N, Tatsuo H, Tanaka K, Minagawa H, Yanagi Y (2001b) V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor. J Virol 75:1594–1600
Panum P (1939) Observations made during the epidemic of measles on the Faroe Islands in the year 1846. Med Classics 3:803–886
Peng KW, Donovan KA, Schneider U, Cattaneo R, Lust JA, Russell SJ (2003) Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker. Blood 101:2557–2562
Plemper RK, Hammond AL, Cattaneo R (2000) Characterization of a region of the measles virus hemagglutinin sufficient for its dimerization. J Virol 74:6485–6493
Plemper RK, Hammond AL, Cattaneo R (2001) Measles virus envelope glycoproteins hetero-oli-gomerize in the endoplasmic reticulum. J Biol Chem 276:44239–44246
Plemper RK, Hammond AL, Gerlier D, Fielding AK, Cattaneo R (2002) Strength of envelope protein interaction modulates cytopathicity of measles virus. J Virol 76:5051–5061
Rager M, Vongpunsawad S, Duprex WP, Cattaneo R (2002) Polyploid measles virus with hexam-eric genome length. EMBO J 21:2364–2372
Richardson C, Hull D, Greer P, Hasel K, Berkovich A, Englund G, et al (1986) The nucleotide sequence of the mRNA encoding the fusion protein of measles virus (Edmonston strain): a comparison of fusion proteins from several different paramyxoviruses. Virology 155:508–523
Schneider U, Bullough F, Vongpunsawad S, Russell SJ, Cattaneo R (2000) Recombinant measles viruses efficiently entering cells through targeted receptors. J Virol 74:9928–9936
Schneider-Schaulies Schnorr JJ, Brinckmann U, Dunster LM, Baczko K, Liebert UG, et al (1995) Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains. Proc Natl Acad Sci USA 92:3943–3947
Springfeld C, von Messling V, Frenzke M, Ungerechts G, Buchholz CJ, Cattaneo R (2006) Oncolytic efficacy and enhanced safety of measles virus activated by tumor-secreted matrix metalloproteinases. Cancer Res 66:7694–7700
Tahara M, Takeda M, Shirogane Y, Hashiguchi T, Ohno S, Yanagi Y (2008) Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J Virol 82:4630–4637
Tatsuo H, Ono N, Tanaka K, Yanagi Y (2000) SLAM (CDw150) is a cellular receptor for measles virus. Nature 406:893–897
Ungerechts G, Springfeld C, Frenzke ME, Lampe J, Johnston PB, Parker WB, et al (2007a) Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can syner-gize with fludarabine. Cancer Res 67:10939–10947
Ungerechts G, Springfeld C, Frenzke ME, Lampe J, Parker WB, Sorscher EJ, Cattaneo R (2007b) An immunocompetent murine model for oncolysis with an armed and targeted measles virus. Mol Ther 15:1991–1997
von Messling V, Svitek N, Cattaneo R (2006) Receptor (SLAM [CD150]) recognition and the V protein sustain swift lymphocyte-based invasion of mucosal tissue and lymphatic organs by a morbillivirus. J Virol 80:6084–6092
Vongpunsawad S, Oezgun N, Braun W, Cattaneo R (2004) Selectively receptor-blind measles viruses: identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol 78:302–313
Watanabe Hirano A, Stenglein S, Nelson J, Thomas G, Wong TC (1995) Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus. J Virol 69:3206–3210
Wild TF, Malvoisin E, Buckland R (1991) Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. J Gen Virol 72:439–442
Yanagi Y, Takeda M, Ohno S (2006) Measles virus: cellular receptors, tropism and pathogenesis. J Gen Virol 87:2767–2779
Yin HS, Wen X, Paterson RG, Lamb RA, Jardetzky TS (2006) Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 439:38–44
Yuan P, Thompson TB, Wurzburg BA, Paterson RG, Lamb RA, Jardetzky TS (2005) Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure 13:803–815
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Navaratnarajah, C.K., Leonard, V.H.J., Cattaneo, R. (2009). Measles Virus Glycoprotein Complex Assembly, Receptor Attachment, and Cell Entry. In: Griffin, D.E., Oldstone, M.B.A. (eds) Measles. Current Topics in Microbiology and Immunology, vol 329. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-70523-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-540-70523-9_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-70522-2
Online ISBN: 978-3-540-70523-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)